Compounded microdoses lack evidence and have FDA warnings
Anti-aging skin support, wound healing, hair restoration, and systemic anti-aging each call for different dosing strategies
Summary: This phase 3a, 68-week, double-blind, placebo-controlled trial investigated the efficacy and safety of coadministering Cagrilintide and Semaglutide
At Concorde, we focus not only on eligibility and appropriate access, but on preparing participants for sustained success on these medications, protecting both outcomes and employer investment
Im not quite getting it just yet
Research consistently shows that longer breastfeeding duration is associated with reduced postpartum weight retention and lower rates of type 2 diabetes